Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127801471 | 12780147 | 1 | I | 20160913 | 20160919 | 20160926 | 20160926 | EXP | BR-GLAXOSMITHKLINE-BR2016GSK139157 | GLAXOSMITHKLINE | 67.70 | YR | F | Y | 90.00000 | KG | 20160926 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127801471 | 12780147 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 UNK, BID | 21077 | 2 | DF | INHALATION POWDER | BID | ||||||
| 127801471 | 12780147 | 2 | SS | BAMIFYLLINE HYDROCHLORIDE | BAMIFYLLINE HYDROCHLORIDE | 1 | Oral | 2 UNK, QD | 0 | 2 | DF | QD | |||||||
| 127801471 | 12780147 | 3 | C | TANDRILAX | ACETAMINOPHENCAFFEINECARISOPRODOLDICLOFENAC SODIUM | 1 | Oral | 1 UNK, WE | U | U | 0 | 1 | DF | /wk | |||||
| 127801471 | 12780147 | 4 | C | CAPTOPRIL. | CAPTOPRIL | 1 | Oral | 1 UNK, TID | U | U | 0 | 1 | DF | TID | |||||
| 127801471 | 12780147 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 1 UNK, QD | 0 | 1 | DF | QD | |||||||
| 127801471 | 12780147 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 127801471 | 12780147 | 7 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MG, QD | U | U | 0 | 100 | MG | QD | |||||
| 127801471 | 12780147 | 8 | C | DIENPAX | DIAZEPAM | 1 | Oral | 1 UNK, QD | U | U | 0 | 1 | DF | QD | |||||
| 127801471 | 12780147 | 9 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 1 UNK, QD | U | U | 0 | 1 | DF | QD | |||||
| 127801471 | 12780147 | 10 | C | CEFALIV | 2 | Oral | 1 UNK, TID | U | U | 0 | 1 | DF | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127801471 | 12780147 | 1 | Emphysema |
| 127801471 | 12780147 | 2 | Emphysema |
| 127801471 | 12780147 | 3 | Pain |
| 127801471 | 12780147 | 4 | Hypertension |
| 127801471 | 12780147 | 5 | Gastric ulcer |
| 127801471 | 12780147 | 6 | Hiatus hernia |
| 127801471 | 12780147 | 7 | Depression |
| 127801471 | 12780147 | 8 | Sedative therapy |
| 127801471 | 12780147 | 9 | Hypertension |
| 127801471 | 12780147 | 10 | Headache |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127801471 | 12780147 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127801471 | 12780147 | Benign uterine neoplasm | |
| 127801471 | 12780147 | Cataract | |
| 127801471 | 12780147 | Cholelithiasis | |
| 127801471 | 12780147 | Headache | |
| 127801471 | 12780147 | Off label use | |
| 127801471 | 12780147 | Pain | |
| 127801471 | 12780147 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |